You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications
|
|---|---|
| Published in |
Frontiers in immunology, November 2016
|
| DOI | 10.3389/fimmu.2016.00500 |
| Pubmed ID | |
| Authors |
Monica Reis, Justyna Ogonek, Marsela Qesari, Nuno M. Borges, Lindsay Nicholson, Liane Preußner, Anne Mary Dickinson, Xiao-nong Wang, Eva M. Weissinger, Anne Richter |
| Abstract |
Allogeneic hematopoietic stem cell transplantation is associated with serious complications, and improvement of the overall clinical outcome of patients with hematological malignancies is necessary. During the last decades, posttransplant donor-derived adoptive cellular immunotherapeutic strategies have been progressively developed for the treatment of graft-versus-host disease (GvHD), infectious complications, and tumor relapses. To date, the common challenge of all these cell-based approaches is their implementation for clinical application. Establishing an appropriate manufacturing process, to guarantee safe and effective therapeutics with simultaneous consideration of economic requirements is one of the most critical hurdles. In this review, we will discuss the recent scientific findings, clinical experiences, and technological advances for cell processing toward the application of mesenchymal stromal cells as a therapy for treatment of severe GvHD, virus-specific T cells for targeting life-threating infections, and of chimeric antigen receptors-engineered T cells to treat relapsed leukemia. |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 4 | 33% |
| United States | 2 | 17% |
| Spain | 1 | 8% |
| Switzerland | 1 | 8% |
| Unknown | 4 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 67% |
| Practitioners (doctors, other healthcare professionals) | 3 | 25% |
| Scientists | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| United States | 1 | 1% |
| Unknown | 75 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 13 | 17% |
| Student > Bachelor | 12 | 16% |
| Researcher | 9 | 12% |
| Student > Master | 6 | 8% |
| Professor > Associate Professor | 5 | 6% |
| Other | 17 | 22% |
| Unknown | 15 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 19% |
| Biochemistry, Genetics and Molecular Biology | 13 | 17% |
| Agricultural and Biological Sciences | 9 | 12% |
| Immunology and Microbiology | 6 | 8% |
| Engineering | 4 | 5% |
| Other | 12 | 16% |
| Unknown | 18 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2016.
All research outputs
#5,140,637
of 25,373,627 outputs
Outputs from Frontiers in immunology
#5,515
of 31,513 outputs
Outputs of similar age
#77,153
of 313,244 outputs
Outputs of similar age from Frontiers in immunology
#43
of 247 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,513 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,244 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 247 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.